Tom F. Brouwer et al. JACEP 2016;2:

Slides:

Advertisements

Similar presentations

Electrocardiographic Eligibility for Subcutaneous Implantable Cardioverter Defibrillator: Evaluation during Bicycle Exercise Matteo Ziacchi, MD, PhD,

Advertisements

Tom F. Brouwer et al. JACEP 2016;2:89-96

Prakash Harikrishnan et al. JACEP 2015;1:

Prakash Harikrishnan et al. JACEP 2015;1:

José L. Morales et al. JACEP 2017;j.jacep

Tom F. Brouwer et al. JACEP 2016;2:

Marwan Badri et al. JACEP 2015;1:

Steven E. Williams et al. JACEP 2015;1:

Masatoshi Yamazaki et al. JACEP 2015;1:

Sigfus Gizurarson et al. JACEP 2016;2:

Pugazhendhi Vijayaraman et al. JACEP 2015;1:

Kenshi Hayashi et al. JACEP 2016;2:

Tom F. Brouwer et al. JACEP 2016;2:89-96

Junjie Zhang et al. JACEP 2017;j.jacep

Masatoshi Yamazaki et al. JACEP 2015;1:

David D. Berg et al. JACC 2018;71:

S.M. Afzal Sohaib et al. JACEP 2015;1:

Tom F. Brouwer et al. JACEP 2016;2:

Junjie Zhang et al. JACEP 2017;3:

Alexander Sedaghat et al. JACEP 2017;3:71-75

Jose C. Pachon M. et al. JACEP 2015;1:

Belinda Gray et al. JCHF 2013;1:

David F. Katz et al. JACEP 2016;j.jacep

Simon W. Rabkin et al. JACEP 2017;j.jacep

Mintu P. Turakhia et al. JACEP 2016;2:

Junaid A.B. Zaman et al. JACEP 2017;3:

Junaid A.B. Zaman et al. JACEP 2017;j.jacep

Junjie Zhang et al. JACEP 2017;3:

Junjie Zhang et al. JACEP 2017;j.jacep

Patrick M. Boyle et al. JACEP 2018;4:

Peter F. Aziz et al. JACEP 2015;1:62-70

Mohit K. Turagam et al. JACEP 2017;3:

Federico Migliore et al. JACEP 2016;2:

Mahesh Anantha Narayanan et al. JACEP 2017;3:

Prabhat Kumar et al. JACEP 2016;j.jacep

Inappropriate shock from delayed T-wave oversensing by a subcutaneous implantable cardioverter-defibrillator after septal myectomy for hypertrophic cardiomyopathy

Mintu P. Turakhia et al. JACEP 2016;2:

Prakash Harikrishnan et al. JACEP 2015;1:

K.R. Julian Chun et al. JACEP 2017;3:

T-wave oversensing during drug challenge test after subcutaneous implantable cardioverter-defibrillator implantation in a patient with Brugada syndrome

Vivek Y. Reddy et al. JACEP 2016;2:

Prabhat Kumar et al. JACEP 2016;j.jacep

Emilce Trucco et al. JACEP 2018;j.jacep

Marwan Badri et al. JACEP 2015;1:

Vittorio Calzolari et al. JACEP 2017;3:

Junjie Zhang et al. JACEP 2017;3:

Kenshi Hayashi et al. JACEP 2016;2:

David F. Katz et al. JACEP 2017;3:20-28

Moussa Mansour et al. JACEP 2016;j.jacep

Alexander Sedaghat et al. JACEP 2016;j.jacep

Ayman A. Hussein et al. JACEP 2017;3:1-9

Mintu P. Turakhia et al. JACEP 2016;2:

Simon W. Rabkin et al. JACEP 2017;3:

Emilce Trucco et al. JACEP 2018;j.jacep

Mahesh Anantha Narayanan et al. JACEP 2017;j.jacep

Pugazhendhi Vijayaraman et al. JACEP 2015;1:

Right-sided subcutaneous implantable cardioverter-defibrillator placement in a patient with dextrocardia, tetralogy of Fallot, and conduction disease

Inappropriate shocks in a patient with a subcutaneous implantable cardioverter- defibrillator Sana M. Al-Khatib, MD, MHS, FHRS, Sasmrita Belbase, NP,

Fred Kusumoto JACEP 2017;j.jacep

Björn Redfors et al. JACEP 2017;j.jacep

Matthew M. Zipse et al. JACEP 2015;1:94-102

Daniele Muser et al. JACEP 2017;j.jacep

Subcutaneous implantable cardioverter-defibrillator implantation in a patient with bilateral pectoral deep brain stimulators Thor Tejada, MD, Faisal.

Jordan S. Leyton-Mange et al. JACEP 2017;j.jacep

Jose C. Pachon M. et al. JACEP 2015;1:

Miyako Igarashi et al. JACEP 2018;4:

Jeffrey L. Anderson et al. JACC 2007;50:e1-e157

Saadia Sherazi et al. JACEP 2015;1:74-80

Ventricular tachycardia slower than the rate cut-off of a subcutaneous cardiac defibrillator sensed and successfully treated as a result of oversensing

Mobile subcutaneous implantable cardioverter-defibrillator leads to oversensing and inappropriate shocks Omid Kiamanesh, MD, Jacob M. Larsen, MD, PhD,

Presentation transcript:

Tom F. Brouwer et al. JACEP 2016;2:605-614 Standard and Algorithm-Based Screening of 2 Patients in Group 1 Algorithm-based screening with the external subcutaneous implantable cardioverter-defibrillator (S-ICD) in 2 patients who were not suitable after standard screening with the dedicated tool both in standing and supine position (red-colored complexes in the upper part of the figure) (Group 1). Patient A in the left panel had adequate sensing in the optimal vector (Primary) during screening with the external S-ICD in rest and during exercise and was deemed suitable (middle part of the figure). This patient was implanted with an S-ICD (lower part of the figure). Patient B in the right panel was deemed not suitable after algorithm-based screening with the external S-ICD, due to T-wave oversensing in the best vector (Primary) both in rest and during exercise (middle part of the figure). This patient was implanted with a S-ICD. S-ECG = subcutaneous electrocardiogram. Tom F. Brouwer et al. JACEP 2016;2:605-614 American College of Cardiology Foundation